16334165

Source:http://linkedlifedata.com/resource/pubmed/id/16334165

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:16334165	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:16334165	lifeskim:mentions	umls-concept:C0013216	lld:lifeskim
pubmed-article:16334165	lifeskim:mentions	umls-concept:C0007131	lld:lifeskim
pubmed-article:16334165	lifeskim:mentions	umls-concept:C0246415	lld:lifeskim
pubmed-article:16334165	lifeskim:mentions	umls-concept:C0282460	lld:lifeskim
pubmed-article:16334165	lifeskim:mentions	umls-concept:C0585332	lld:lifeskim
pubmed-article:16334165	lifeskim:mentions	umls-concept:C1521801	lld:lifeskim
pubmed-article:16334165	lifeskim:mentions	umls-concept:C0205179	lld:lifeskim
pubmed-article:16334165	pubmed:issue	6C	lld:pubmed
pubmed-article:16334165	pubmed:dateCreated	2005-12-7	lld:pubmed
pubmed-article:16334165	pubmed:abstractText	The aim of this phase II study was to evaluate efficacy and toxicity of single-agent docetaxel, administered every two weeks as second-line treatment for patients with recurrent non-small cell lung cancer (NSCLC).	lld:pubmed
pubmed-article:16334165	pubmed:language	eng	lld:pubmed
pubmed-article:16334165	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:16334165	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:16334165	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:16334165	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:16334165	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:16334165	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:16334165	pubmed:issn	0250-7005	lld:pubmed
pubmed-article:16334165	pubmed:author	pubmed-author:De...	lld:pubmed
pubmed-article:16334165	pubmed:author	pubmed-author:Di...	lld:pubmed
pubmed-article:16334165	pubmed:author	pubmed-author:MartelliOlgaO	lld:pubmed
pubmed-article:16334165	pubmed:author	pubmed-author:De...	lld:pubmed
pubmed-article:16334165	pubmed:author	pubmed-author:MancusoAndrea...	lld:pubmed
pubmed-article:16334165	pubmed:author	pubmed-author:MigliorinoMar...	lld:pubmed
pubmed-article:16334165	pubmed:author	pubmed-author:CeribelliAnna...	lld:pubmed
pubmed-article:16334165	pubmed:author	pubmed-author:De...	lld:pubmed
pubmed-article:16334165	pubmed:author	pubmed-author:Di...	lld:pubmed
pubmed-article:16334165	pubmed:issnType	Print	lld:pubmed
pubmed-article:16334165	pubmed:volume	25	lld:pubmed
pubmed-article:16334165	pubmed:owner	NLM	lld:pubmed
pubmed-article:16334165	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:16334165	pubmed:pagination	4713-7	lld:pubmed
pubmed-article:16334165	pubmed:meshHeading	pubmed-meshheading:16334165...	lld:pubmed
pubmed-article:16334165	pubmed:meshHeading	pubmed-meshheading:16334165...	lld:pubmed
pubmed-article:16334165	pubmed:meshHeading	pubmed-meshheading:16334165...	lld:pubmed
pubmed-article:16334165	pubmed:meshHeading	pubmed-meshheading:16334165...	lld:pubmed
pubmed-article:16334165	pubmed:meshHeading	pubmed-meshheading:16334165...	lld:pubmed
pubmed-article:16334165	pubmed:meshHeading	pubmed-meshheading:16334165...	lld:pubmed
pubmed-article:16334165	pubmed:meshHeading	pubmed-meshheading:16334165...	lld:pubmed
pubmed-article:16334165	pubmed:meshHeading	pubmed-meshheading:16334165...	lld:pubmed
pubmed-article:16334165	pubmed:meshHeading	pubmed-meshheading:16334165...	lld:pubmed
pubmed-article:16334165	pubmed:meshHeading	pubmed-meshheading:16334165...	lld:pubmed
pubmed-article:16334165	pubmed:meshHeading	pubmed-meshheading:16334165...	lld:pubmed
pubmed-article:16334165	pubmed:meshHeading	pubmed-meshheading:16334165...	lld:pubmed
pubmed-article:16334165	pubmed:articleTitle	Docetaxel administered every two weeks as second-line chemotherapy for advanced non-small cell lung cancer: a phase II study.	lld:pubmed
pubmed-article:16334165	pubmed:affiliation	5th Pneumo-Oncology Unit, Department of Oncology, S. Camillo-Forlanini Hospitals, V. Portuense 332, 00149 Rome, Italy.	lld:pubmed
pubmed-article:16334165	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:16334165	pubmed:publicationType	Clinical Trial, Phase II	lld:pubmed